Back to Journals » OncoTargets and Therapy » Volume 11

OncoTargets and Therapy


Archive: Volume 11, 2018

miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway

Li C, Zhang J, Ma Z, Zhang F, Yu W

OncoTargets and Therapy 2018, 11:4087-4095

Published Date: 16 July 2018

MicroRNA-384 inhibits proliferation migration and invasion of glioma by targeting at CDC42

Gu G, Wang L, Zhang J, Wang H, Tan T, Zhang G

OncoTargets and Therapy 2018, 11:4075-4085

Published Date: 16 July 2018

MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9)

Liu R, Wang F, Guo Y, Yang J, Chen S, Gao X, Wang X

OncoTargets and Therapy 2018, 11:4065-4073

Published Date: 16 July 2018

New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab

Bylicki O, Paleiron N, Rousseau-Bussac G, Chouaïd C

OncoTargets and Therapy 2018, 11:4051-4064

Published Date: 16 July 2018

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma

Li X, Li X, Fang X, Yuan Y

OncoTargets and Therapy 2018, 11:4047-4050

Published Date: 16 July 2018

MSI2 knockdown represses extrahepatic cholangiocarcinoma growth and invasion by inhibiting epithelial–mesenchymal transition

Hu F, Liu C, Xie F, Lin X, Yang J, Wang C, Huang Q

OncoTargets and Therapy 2018, 11:4035-4046

Published Date: 13 July 2018

Downregulation and DNA methylation of ECRG4 in gastric cancer

Deng P, Chang XJ, Gao ZM, Xu XY, Sun AQ, Li K, Dai DQ

OncoTargets and Therapy 2018, 11:4019-4028

Published Date: 13 July 2018

MFAP2 promotes epithelial–mesenchymal transition in gastric cancer cells by activating TGF-β/SMAD2/3 signaling pathway

Wang JK, Wang WJ, Cai HY, Du BB, Mai P, Zhang LJ, Ma W, Hu YG, Feng SF, Miao GY

OncoTargets and Therapy 2018, 11:4001-4017

Published Date: 12 July 2018

The effect of tubeimoside-1 on the proliferation, metastasis and apoptosis of oral squamous cell carcinoma in vitro

Wu T, Cui H, Xu Y, Du Q, Zhao E, Cao J, Nie L, Fu G, Ren A

OncoTargets and Therapy 2018, 11:3989-4000

Published Date: 10 July 2018

Increased expression of antisense lncRNA SPINT1-AS1 predicts a poor prognosis in colorectal cancer and is negatively correlated with its sense transcript

Li C, Li W, Zhang YL, Zhang X, Liu T, Zhang Y, Yang YM, Wang LL, Pan HW, Ji J, Wang CX

OncoTargets and Therapy 2018, 11:3969-3978

Published Date: 10 July 2018

SIRT4 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, migration, and invasion

Sun H, Huang D, Liu G, Jian F, Zhu J, Zhang L

OncoTargets and Therapy 2018, 11:3959-3968

Published Date: 10 July 2018

Immunohistochemical expression of hormone receptors, Ki-67, endoglin (CD105), claudins 3 and 4, MMP -2 and -9 in endometrial polyps and endometrial cancer type I

Peres GF, Spadoto-Dias D, Bueloni-Dias FN, Leite NJ, Elias LV, Domingues MA, Padovani CR, Dias R

OncoTargets and Therapy 2018, 11:3949-3958

Published Date: 9 July 2018

Overexpression of DJ-1 correlates with aggressive clinicopathological characteristics and poor prognosis in malignant tumors: a meta-analysis

Wang Q, Li F, Shi W, Zhang Q, Wang J, Yan X, Chai L, Li M

OncoTargets and Therapy 2018, 11:3931-3942

Published Date: 9 July 2018

Predictive value of single nucleotide polymorphisms in XRCC1 for radiation-induced normal tissue toxicity

Zhao J, Zhi Z, Zhang M, Li Q, Li J, Wang X, Ma C

OncoTargets and Therapy 2018, 11:3901-3918

Published Date: 6 July 2018

MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer

Yuan HL, Wang T, Zhang KH

OncoTargets and Therapy 2018, 11:3891-3900

Published Date: 6 July 2018

The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study

Song W, Yu JW, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Kang ES, Jeon HG

OncoTargets and Therapy 2018, 11:3883-3889

Published Date: 6 July 2018

Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma

Jin J, Okamoto R, Yoon SS, Shih LY, Zhu J, Liu T, Hong XN, Pei L, Rooney B, van de Velde H, Huang HQ

OncoTargets and Therapy 2018, 11:3869-3882

Published Date: 6 July 2018

Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression

Zhang H, Lian Z, Sun G, Liu R, Xu Y

OncoTargets and Therapy 2018, 11:3853-3867

Published Date: 6 July 2018

The role of histone lysine methyltransferase NSD3 in cancer

Han X, Piao L, Zhuang Q, Yuan X, Liu Z, He X

OncoTargets and Therapy 2018, 11:3847-3852

Published Date: 5 July 2018

miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA

Ni S, Weng W, Xu M, Wang Q, Tan C, Sun H, Wang L, Huang D, Du X, Sheng W

OncoTargets and Therapy 2018, 11:3835-3845

Published Date: 4 July 2018

Silencing of c-jun decreases cell migration, invasion, and EMT in radioresistant human nasopharyngeal carcinoma cell line CNE-2R

Lin G, Yu B, Liang Z, Li L, Qu S, Chen K, Zhou L, Lu Q, Sun Y, Zhu X

OncoTargets and Therapy 2018, 11:3805-3815

Published Date: 4 July 2018

A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer

Lu H, Wu Y, Liu X, Jiang H, Pang Q, Peng L, Cheng J, Deng S, Gu J, Zhao R, Hu X, Chen C, Yu J

OncoTargets and Therapy 2018, 11:3785-3792

Published Date: 2 July 2018

SIL1 functions as an oncogene in glioma by AKT/mTOR signaling pathway

Xu H, Xu S, Zhang R, Xin T, Pang Q

OncoTargets and Therapy 2018, 11:3775-3783

Published Date: 2 July 2018

Angiogenesis and vasculogenic mimicry are inhibited by 8-Br-cAMP through activation of the cAMP/PKA pathway in colorectal cancer

Wang S, Zhang Z, Qian W, Ji D, Wang Q, Ji B, Zhang Y, Zhang C, Sun Y, Zhu C, Sun Y

OncoTargets and Therapy 2018, 11:3765-3774

Published Date: 2 July 2018

Primary effusion lymphoma: current perspectives

Narkhede M, Arora S, Ujjani C

OncoTargets and Therapy 2018, 11:3747-3754

Published Date: 28 June 2018

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers

Wolf GT, Moyer JS, Kaplan MJ, Newman JG, Egan JE, Berinstein NL, Whiteside TL

OncoTargets and Therapy 2018, 11:3731-3746

Published Date: 28 June 2018

Nuclear factor-κB p65 regulates glutaminase 1 expression in human hepatocellular carcinoma

Dong M, Miao L, Zhang F, Li S, Han J, Yu R, Qie S

OncoTargets and Therapy 2018, 11:3721-3729

Published Date: 28 June 2018

Targeted therapy and immunotherapy for platinum-refractory advanced ovarian adenosquamous carcinoma: a case report

Li A, Sun S, Song T, Li X, Cheng W, Yao R, Zhang D, Cai Z, Zhang J, Zhai D, Yu C

OncoTargets and Therapy 2018, 11:3705-3711

Published Date: 27 June 2018

An uncommon granulocytic sarcoma of the breast: a case report and literature review

Zhai J, Kong X, Yang X, Gao J, Xuan L, Wang X, Wang J, Fang Y

OncoTargets and Therapy 2018, 11:3685-3690

Published Date: 25 June 2018

Prognostic impact of the number of lymph nodes examined in different stages of colorectal mucinous adenocarcinoma

Ma Y, Luo YQ, Lin N, Lv YZ, Zhou Y, Li B, Han KN, Jiang S, Gao JJ

OncoTargets and Therapy 2018, 11:3659-3670

Published Date: 25 June 2018

lincROR influences the stemness and crizotinib resistance in EML–ALK+ non-small-cell lung cancer cells

Yang Y, Huang J, Xie N, Huang H, Xu S, Cai J, Qi S

OncoTargets and Therapy 2018, 11:3649-3657

Published Date: 22 June 2018

TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma

Wang H, Fang ZL, Zhang GH, Ma X

OncoTargets and Therapy 2018, 11:3637-3647

Published Date: 21 June 2018

Whole-body MRI versus 18F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis

Wang D, Huo Y, Chen S, Wang H, Ding Y, Zhu X, Ma C

OncoTargets and Therapy 2018, 11:3597-3608

Published Date: 20 June 2018

Impact of RNA integrity and blood sample storage conditions on the gene expression analysis

Shen YT, Li R, Tian F, Chen ZZ, Lu N, Bai YF, Ge QY, Lu ZH

OncoTargets and Therapy 2018, 11:3573-3581

Published Date: 20 June 2018

Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis

Liang C, Zhao J, Ge H, Li G, Wu J

OncoTargets and Therapy 2018, 11:3561-3571

Published Date: 19 June 2018

The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER

Tang J, Kong D, Cui Q, Wang K, Zhang D, Liao X, Gong Y, Wu G

OncoTargets and Therapy 2018, 11:3551-3560

Published Date: 19 June 2018

Prognostic value of miR-17-5p in cancers: a meta-analysis

Kong W, Cheng Y, Liang H, Chen Q, Xiao C, Li K, Huang Z, Zhang J

OncoTargets and Therapy 2018, 11:3541-3549

Published Date: 19 June 2018

Combined small-cell lung carcinoma

Qin J, Lu H

OncoTargets and Therapy 2018, 11:3505-3511

Published Date: 19 June 2018

Association between common polymorphisms in ERCC gene and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis

Li C, Yu X, Guo D, Liu G, Zhang K, Teng Q, Lin H

OncoTargets and Therapy 2018, 11:3495-3504

Published Date: 18 June 2018

Downregulation of ribophorin II suppresses tumor growth, migration, and invasion of nasopharyngeal carcinoma

Hong F, Li Y, Ni H, Li J

OncoTargets and Therapy 2018, 11:3485-3494

Published Date: 15 June 2018

STAT3 induces colorectal carcinoma progression through a novel miR-572-MOAP-1 pathway

Wang N, He X, Zhou R, Jia G, Qiao Q

OncoTargets and Therapy 2018, 11:3475-3484

Published Date: 15 June 2018

MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS

Chang J, Xu W, Du X, Hou J

OncoTargets and Therapy 2018, 11:3461-3473

Published Date: 15 June 2018

The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis

Li J, Cheng Y, Liu G, Ji Z

OncoTargets and Therapy 2018, 11:3449-3459

Published Date: 15 June 2018

Effectiveness of lomustine and bevacizumab in progressive glioblastoma: a meta-analysis

Song J, Xue YQ, Zhao MM, Xu P

OncoTargets and Therapy 2018, 11:3435-3439

Published Date: 13 June 2018

Twenty-gene-based prognostic model predicts lung adenocarcinoma survival

Zhao K, Li Z, Tian H

OncoTargets and Therapy 2018, 11:3415-3424

Published Date: 12 June 2018

Identification of CD24 as a marker for tumorigenesis of melanoma

Tang MR, Guo JY, Wang D, Xu N

OncoTargets and Therapy 2018, 11:3401-3406

Published Date: 12 June 2018

Expression and functional characterization of FOXM1 in non-small cell lung cancer

Zhang Y, Qiao W, Shan L

OncoTargets and Therapy 2018, 11:3385-3393

Published Date: 11 June 2018

Prognostic value of spleen tyrosine kinase in human solid tumors

Ni B, Li S, Liu Y, Huang Y, Li Z

OncoTargets and Therapy 2018, 11:3377-3384

Published Date: 8 June 2018

Meta-analysis of segmentectomy versus wedge resection in stage IA non-small-cell lung cancer

Xue WF, Duan GC, Zhang XP, Zhang H, Zhao QT, Xin ZF

OncoTargets and Therapy 2018, 11:3369-3375

Published Date: 7 June 2018

Effect of AQP-5 silencing by siRNA interference on chemosensitivity of breast cancer cells

Li X, Pei B, Wang H, Tang C, Zhu W, Jin F

OncoTargets and Therapy 2018, 11:3359-3368

Published Date: 6 June 2018

Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics

Liu X, Weng Y, Liu P, Sui Z, Zhou L, Huang Y, Zhang L, Zhang Y, Tan X

OncoTargets and Therapy 2018, 11:3345-3357

Published Date: 6 June 2018

Comparison of detection methods of EGFR T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer

Kobayashi K, Naoki K, Manabe T, Masuzawa K, Hasegawa H, Yasuda H, Kawada I, Soejima K, Betsuyaku T

OncoTargets and Therapy 2018, 11:3335-3343

Published Date: 6 June 2018

Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling

Yan J, Du P, Jia Y, Chang Z, Gan S, Xu X, Wang Y, Qin Y, Kan Q

OncoTargets and Therapy 2018, 11:3323-3333

Published Date: 6 June 2018

Novel quinazoline-based sulfonamide derivative (3D) induces apoptosis in colorectal cancer by inhibiting JAK2–STAT3 pathway

Al-Obeed O, Vaali-Mohammed MA, Eldehna WM, Al-Khayal K, Mahmood A, Abdel-Aziz HA, Zubaidi A, Alafeefy A, Abdulla M, Ahmad R

OncoTargets and Therapy 2018, 11:3313-3322

Published Date: 5 June 2018

Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer

Ni J, Peng Y, Yang F, Xi X, Huang X, He C

OncoTargets and Therapy 2018, 11:3303-3312

Published Date: 5 June 2018

Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1

Chen Y, Zhang F, Zhao Y, He K, Zheng X, Pan Y, Shao D, Shang P, Yang Y, Zhang D, Xie Y, Yao X, Chen L, Li J, Zhang X

OncoTargets and Therapy 2018, 11:3281-3292

Published Date: 1 June 2018

Association of VDR gene TaqI polymorphism with the susceptibility to prostate cancer in Asian population evaluated by an updated systematic meta-analysis

Chen L, Wei J, Zhang S, Lou Z, Wang X, Ren Y, Qi H, Xie Z, Chen Y, Chen F, Wu Q, Fan X, Xu H, Huang S, Weng G

OncoTargets and Therapy 2018, 11:3267-3280

Published Date: 31 May 2018

A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma

Xie H, Tian S, Yu H, Yang X, Liu J, Wang H, Feng F, Guo Z

OncoTargets and Therapy 2018, 11:3257-3265

Published Date: 31 May 2018

Prognostic role of plasma mammaglobin A expression in breast carcinoma patients: a meta-analysis

Hu YY, Liu P, Wu D, Jiang YH

OncoTargets and Therapy 2018, 11:3245-3255

Published Date: 30 May 2018

Prognostic significance of galectin-1 and vasculogenic mimicry in patients with gastric cancer

You X, Wang Y, Wu J, Liu Q, Chen D, Tang D, Wang D

OncoTargets and Therapy 2018, 11:3237-3244

Published Date: 29 May 2018

Association between KIF1B (rs17401966) polymorphism and hepatocellular carcinoma susceptibility: a meta-analysis

Zhang Y, Zeng X, Lu H, Ji H, Lu L, Liu P, Hong R, Li Y

OncoTargets and Therapy 2018, 11:3225-3235

Published Date: 29 May 2018

Knockdown of long noncoding RNA 00152 (LINC00152) inhibits human retinoblastoma progression

Li S, Wen D, Che S, Cui Z, Sun Y, Ren H, Hao J

OncoTargets and Therapy 2018, 11:3215-3223

Published Date: 6 June 2018

Periostin overexpression is associated with worse prognosis in nasopharyngeal carcinoma from endemic area: a cohort study

Wei YC, Yang SF, Chang SL, Chen TJ, Lee SW, Chen HS, Lin LC, Li CF

OncoTargets and Therapy 2018, 11:3205-3213

Published Date: 29 May 2018

Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion

Gu S, Liang H, Qi D, Mao L, Mao G, Qian L, Zhang S

OncoTargets and Therapy 2018, 11:3195-3203

Published Date: 29 May 2018

Emerging role of long non-coding RNAs in cisplatin resistance

Hu Y, Zhu QN, Deng JL, Li ZX, Wang G, Zhu YS

OncoTargets and Therapy 2018, 11:3185-3194

Published Date: 28 May 2018

A large and aggressive fibromatosis in the axilla: a rare case report and review of the literature

Duan M, Xing H, Wang K, Niu C, Jiang C, Zhang L, Ezzat S, Zhang L

OncoTargets and Therapy 2018, 11:3179-3184

Published Date: 28 May 2018

Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer

Wang K, Ruan H, Xu T, Liu L, Liu D, Yang H, Zhang X, Chen K

OncoTargets and Therapy 2018, 11:3167-3178

Published Date: 28 May 2018

CEACAM6 is associated with osteosarcoma metastasis and facilitates epithelial–mesenchymal transition in osteosarcoma cells

Wang Z, Luo C, Wang H, Yan X, Liu W, Meng Z

OncoTargets and Therapy 2018, 11:3159-3166

Published Date: 28 May 2018

High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer

Zhang M, Li X, Fan Z, Zhao J, Liu S, Zhang M, Li H, Goscinski MA, Fan H, Suo Z

OncoTargets and Therapy 2018, 11:3149-3157

Published Date: 28 May 2018

miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells

Chen K, Chen Y, Chen Z, Shi Y, He Z, Ding B, Wang C, Yu L

OncoTargets and Therapy 2018, 11:3141-3147

Published Date: 25 May 2018

Construction of a specific SVM classifier and identification of molecular markers for lung adenocarcinoma based on lncRNA-miRNA-mRNA network

Zhao J, Cheng W, He X, Liu Y, Li J, Sun J, Li J, Wang F, Gao Y

OncoTargets and Therapy 2018, 11:3129-3140

Published Date: 25 May 2018

The incidence and predictors of symptomatic venous thromboembolism associated with peripherally inserted central catheters in patients with nasopharyngeal carcinoma

Liang YJ, He Y, Li JM, Chen LM, Chen LP, Wang C, Ji L, Li ZX, Tang LQ, Chen QY, Fan YY, Hu W

OncoTargets and Therapy 2018, 11:3119-3127

Published Date: 25 May 2018

Overexpression of MCPH1 inhibits the migration and invasion of lung cancer cells

Wu X, Liu W, Liu X, Ai Q, Yu J

OncoTargets and Therapy 2018, 11:3111-3117

Published Date: 25 May 2018

Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma

Lin MH, Lv D, Zheng YL, Wu ML, Xu C, Zhang Q, Wu LH

OncoTargets and Therapy 2018, 11:3101-3110

Published Date: 25 May 2018

Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis

Liu X, Zhao Y, Zhang W, Gao Y, Huo M, Liu M, Xiao Z, Liang S, Xu N, Zhu H

OncoTargets and Therapy 2018, 11:3087-3100

Published Date: 24 May 2018

Gene expression and prognosis of NOX family members in gastric cancer

You X, Ma M, Hou G, Hu Y, Shi X

OncoTargets and Therapy 2018, 11:3065-3074

Published Date: 24 May 2018

High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis

Yang XH, Zang H, Luo Y, Wu J, Fang Z, Zhu W, Li Y

OncoTargets and Therapy 2018, 11:3035-3046

Published Date: 23 May 2018

LGR6 promotes the progression of gastric cancer through PI3K/AKT/mTOR pathway

Ke J, Ma P, Chen J, Qin J, Qian H

OncoTargets and Therapy 2018, 11:3025-3033

Published Date: 22 May 2018

Expression of HSP90AA1/HSPA8 in hepatocellular carcinoma patients with depression

Xiang X, You XM, Li LQ

OncoTargets and Therapy 2018, 11:3013-3023

Published Date: 22 May 2018

The role of HIF-1α in chemo-/radioresistant tumors

Xia Y, Jiang L, Zhong T

OncoTargets and Therapy 2018, 11:3003-3011

Published Date: 22 May 2018

The methylation profiles of PRDM promoters in non–small cell lung cancer

Tan SX, Hu RC, Xia Q, Tan YL, Liu JJ, Gan GX, Wang LL

OncoTargets and Therapy 2018, 11:2991-3002

Published Date: 22 May 2018

Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-2

Li X, Li F, Wang FF, Li JF, Lin CZ, Du JX

OncoTargets and Therapy 2018, 11:2981-2989

Published Date: 22 May 2018

Intra-arterial chemotherapy improved survival of stage 2–3 gallbladder cancer after curative resection

Chen C, Feng W, Zheng Y, Bao Y, Feng M

OncoTargets and Therapy 2018, 11:2975-2979

Published Date: 22 May 2018

Ovol2 induces mesenchymal–epithelial transition via targeting ZEB1 in osteosarcoma

Liu J, Wu Q, Wang Y, Wei Y, Wu H, Duan L, Zhang Q, Wu Y

OncoTargets and Therapy 2018, 11:2963-2973

Published Date: 22 May 2018

Downregulation of STARD8 in gastric cancer and its involvement in gastric cancer progression

Zhang S, Chang X, Ma J, Chen J, Zhi Y, Li Z, Dai D

OncoTargets and Therapy 2018, 11:2955-2961

Published Date: 21 May 2018

Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells

Wu M, Zhao G, Zhuang X, Zhang T, Zhang C, Zhang W, Zhang Z

OncoTargets and Therapy 2018, 11:2945-2954

Published Date: 18 May 2018

Indirubin inhibits cell proliferation, migration, invasion and angiogenesis in tumor-derived endothelial cells

Li Z, Zhu C, An B, Chen Y, He X, Qian L, Lan L, Li S

OncoTargets and Therapy 2018, 11:2937-2944

Published Date: 18 May 2018

Downregulation of PDIA3 inhibits proliferation and invasion of human acute myeloid leukemia cells

Ye Q, Fu P, Dou J, Wang N

OncoTargets and Therapy 2018, 11:2925-2935

Published Date: 17 May 2018

miR-598 acts as a tumor suppressor in human gastric cancer by targeting IGF-1R

Liu N, Yang H, Wang H

OncoTargets and Therapy 2018, 11:2911-2923

Published Date: 17 May 2018

High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients

Mandó P, Rizzo M, Roberti MP, Juliá EP, Pampena MB, Pérez de la Puente C, Loza CM, Ponce C, Nadal J, Coló FA, Mordoh J, Levy EM

OncoTargets and Therapy 2018, 11:2901-2910

Published Date: 17 May 2018

Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer

Wang Y, Liu J, Yang X, Liu Y, Liu Y, Li Y, Sun L, Yang X, Niu H

OncoTargets and Therapy 2018, 11:2891-2899

Published Date: 16 May 2018

RIP1 regulates TNF-α-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-κB-VEGF-C pathway

Li C, Jiang X, Lin B, Hong H, Zhu S, Jiang L, Wang X, Tang N, She F, Chen Y

OncoTargets and Therapy 2018, 11:2875-2890

Published Date: 16 May 2018

circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma

Zhang XW, Luo P, Jing W, Zhou H, Liang CZ, Tu JC

OncoTargets and Therapy 2018, 11:2853-2863

Published Date: 16 May 2018

NDRG3 facilitates colorectal cancer metastasis through activating Src phosphorylation

Li T, Sun R, Lu MD, Chang J, Meng X, Wu H

OncoTargets and Therapy 2018, 11:2843-2852

Published Date: 15 May 2018

Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect

Shen J, Zhu X, Fei J, Shi P, Yu S, Zhou J

OncoTargets and Therapy 2018, 11:2831-2841

Published Date: 15 May 2018

Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis

Zhou X, Huang X, Liang S, Tang S, Wu S, Huang T, Mo Z, Wang Q

OncoTargets and Therapy 2018, 11:2815-2830

Published Date: 15 May 2018

Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer

Llueca A, Serra A, Herraiz JL, Rivadulla I, Gomez-Quiles L, Gilabert-Estelles J, Escrig J

OncoTargets and Therapy 2018, 11:2771-2777

Published Date: 15 May 2018

ZNF418 overexpression protects against gastric carcinoma and prompts a good prognosis

Hui H, Hu Z, Jiang C, Wu J, Gao Y, Wang X

OncoTargets and Therapy 2018, 11:2763-2770

Published Date: 11 May 2018

Upregulation of circ_0066444 promotes the proliferation, invasion, and migration of gastric cancer cells

Rong D, Dong C, Fu K, Wang H, Tang W, Cao H

OncoTargets and Therapy 2018, 11:2753-2761

Published Date: 11 May 2018

Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter

Zhang Q, Huang R, Tang Q, Yu Y, Huang Q, Chen Y, Wang G, Wang X

OncoTargets and Therapy 2018, 11:2745-2752

Published Date: 11 May 2018

Aloperine executes antitumor effects through the induction of apoptosis and cell cycle arrest in prostate cancer in vitro and in vivo

Ling Z, Guan H, You Z, Wang C, Hu L, Zhang L, Wang Y, Chen S, Xu B, Chen M

OncoTargets and Therapy 2018, 11:2735-2743

Published Date: 11 May 2018

Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer

Feng Y, Dai Y, Gong Z, Cheng JN, Zhang L, Sun C, Zeng X, Jia Q, Zhu B

OncoTargets and Therapy 2018, 11:2725-2733

Published Date: 10 May 2018

Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case–control studies

Chen Q, Yuan H, Shi GD, Wu Y, Liu D, Lin YT, Chen L, Ge W, Jiang K, Miao Y

OncoTargets and Therapy 2018, 11:2709-2723

Published Date: 9 May 2018

Clinical relevance of lysyl oxidase-like 2 and functional mechanisms in glioma

Du XG, Zhu MJ

OncoTargets and Therapy 2018, 11:2699-2708

Published Date: 9 May 2018

Delivery of bevacizumab by intracranial injection: assessment in glioma model

Liu YX, Liu WJ, Zhang HR, Zhang ZW

OncoTargets and Therapy 2018, 11:2673-2683

Published Date: 8 May 2018

Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis

Zhang T, Feng F, Zhao W, Tian J, Yao Y, Zhou C, Dong S, Wang C, Zang C, Lv Q, Sun C

OncoTargets and Therapy 2018, 11:2647-2656

Published Date: 8 May 2018

The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients

Cao L, Long L, Li M, Yang H, Deng P, Mao X, Xiang J, Li B, Zhang T, Hu C

OncoTargets and Therapy 2018, 11:2637-2646

Published Date: 8 May 2018

Predicting initial margin status in breast cancer patients during breast-conserving surgery

Pan Z, Zhu L, Li Q, Lai J, Peng J, Su F, Li S, Chen K

OncoTargets and Therapy 2018, 11:2627-2635

Published Date: 8 May 2018

Are ovarian cancer stem cells the target for innovative immunotherapy?

Wang L, Xu T, Cui M

OncoTargets and Therapy 2018, 11:2615-2626

Published Date: 8 May 2018

A 5-serum miRNA panel for the early detection of colorectal cancer

Guo S, Zhang J, Wang B, Zhang B, Wang X, Huang L, Liu H, Jia B

OncoTargets and Therapy 2018, 11:2603-2614

Published Date: 8 May 2018

Chelerythrine induced cell death through ROS-dependent ER stress in human prostate cancer cells

Wu S, Yang Y, Li F, Huang L, Han Z, Wang G, Yu H, Li H

OncoTargets and Therapy 2018, 11:2593-2601

Published Date: 8 May 2018

WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling

Han Q, Kremerskothen J, Lin X, Zhang X, Rong X, Zhang D, Wang E

OncoTargets and Therapy 2018, 11:2581-2591

Published Date: 8 May 2018

Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study

Bai Y, Gao XS, Qin SB, Chen JY, Su MM, Liu Q, Qin XB, Ma MW, Zhao B, Gu XB, Xie M, Cui M, Qi X, Li XY

OncoTargets and Therapy 2018, 11:2571-2579

Published Date: 8 May 2018

Fatal hemoptysis in patients with advanced esophageal cancer treated with apatinib

Wang W, Zhang L, Xie Y, Zhen TC, Su GZ, Zang Q

OncoTargets and Therapy 2018, 11:2565-2570

Published Date: 7 May 2018

Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival

Ma L, Qiu JR, Zhang YD, Qiu TZ, Wang B, Chen WS, Li X, Sun J, Wang K, Li XC, Gu YH, Shu YQ, Chen XF

OncoTargets and Therapy 2018, 11:2533-2543

Published Date: 4 May 2018

The genetic association between iNOS and eNOS polymorphisms and gastric cancer risk: a meta-analysis

Zhu Y, Jiang HG, Chen ZH, Lu BH, Li J, Peng YP, Shen XN

OncoTargets and Therapy 2018, 11:2497-2507

Published Date: 3 May 2018

Pretreatment hematologic markers as prognostic predictors of gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis

Zhou Y, Li D, Lin Y, Yu M, Lu X, Jian Z, Na N, Hou B

OncoTargets and Therapy 2018, 11:2489-2496

Published Date: 1 May 2018

UCA1 promotes cell proliferation and invasion and inhibits apoptosis through regulation of the miR129–SOX4 pathway in renal cell carcinoma

Liu Q, Li Y, Lv W, Zhang G, Tian X, Li X, Cheng H, Zhu C

OncoTargets and Therapy 2018, 11:2475-2487

Published Date: 1 May 2018

Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer

Yang Q, Huang YY, Jiang ZM, Wang HZ, Li WY, Zhang B, Xie DR

OncoTargets and Therapy 2018, 11:2467-2473

Published Date: 1 May 2018

The CXCL12 rs1801157 polymorphism and risk of colorectal cancer: a meta-analysis

Xu K, Dai H, Wang S, Zhang J, Liu T

OncoTargets and Therapy 2018, 11:2445-2452

Published Date: 1 May 2018

A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure

Xiao W, Que Y, Peng RQ, Ding Y, Zhao JJ, Wen XZ, Weng DS, Zhang XS, Guan YX, Zhang X

OncoTargets and Therapy 2018, 11:2439-2443

Published Date: 1 May 2018

Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9

Sang S, Liu X, Sun D

OncoTargets and Therapy 2018, 11:2429-2438

Published Date: 30 April 2018

A meta-analytic review of the association between two common SNPs in miRNAs and lung cancer susceptibility

Xiao S, Sun S, Long W, Kuang S, Liu Y, Huang H, Zhou J, Zhou Y, Lu X

OncoTargets and Therapy 2018, 11:2419-2427

Published Date: 30 April 2018

Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell-cycle arrest

Yang LF, Liu HR, Long M, Wang X, Lin F, Gao ZW, Zhang HZ

OncoTargets and Therapy 2018, 11:2409-2417

Published Date: 30 April 2018

A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumors

Bauer TM, Patel MR, Forero-Torres A, George TJ Jr, Assad A, Du Y, Hurwitz H

OncoTargets and Therapy 2018, 11:2399-2407

Published Date: 30 April 2018

Role of Beclin1 expression in patients with hepatocellular carcinoma: a meta-analysis

Liang C, Li W, Ge H, Zhang KT, Li GM, Wu J

OncoTargets and Therapy 2018, 11:2387-2397

Published Date: 27 April 2018

LDH-A promotes epithelial–mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer

Zhang Y, Lin S, Chen Y, Yang F, Liu S

OncoTargets and Therapy 2018, 11:2363-2373

Published Date: 27 April 2018

Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer

Wang WW, Zhou XL, Song YJ, Yu CH, Zhu WG, Tong YS

OncoTargets and Therapy 2018, 11:2333-2344

Published Date: 24 April 2018

MicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2

Tang W, Xu P, Wang H, Niu Z, Zhu D, Lin Q, Tang L, Ren L

OncoTargets and Therapy 2018, 11:2319-2332

Published Date: 24 April 2018

Risk factors for esophageal fistula in patients with locally advanced esophageal carcinoma receiving chemoradiotherapy

Zhang Y, Li Z, Zhang W, Chen W, Song Y

OncoTargets and Therapy 2018, 11:2311-2317

Published Date: 23 April 2018

Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report

Duan H, Peng Y, Cui H, Qiu Y, Li Q, Zhang J, Shen W, Sun C, Luo C

OncoTargets and Therapy 2018, 11:2303-2309

Published Date: 23 April 2018

Neuroendocrine tumor of the common bile duct: a case report and review of the literature

Liu Z, Zhang DY, Lu Z, Zhang P, Sun WL, Ma X, Wu H, Wu BQ, Zhou S

OncoTargets and Therapy 2018, 11:2295-2301

Published Date: 23 April 2018

Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review

Makita S, Maeshima AM, Maruyama D, Izutsu K, Tobinai K

OncoTargets and Therapy 2018, 11:2287-2293

Published Date: 20 April 2018

Oncogene mutational analysis in Chinese gastrointestinal stromal tumor patients

Chen Q, Li R, Zhang Z, Deng Q, Li K, Wang H, Yang X, Wu Y

OncoTargets and Therapy 2018, 11:2279-2286

Published Date: 20 April 2018

Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67

Xu J, Guo X, Jing M, Sun T

OncoTargets and Therapy 2018, 11:2269-2275

Published Date: 19 April 2018

Role of DiGeorge syndrome critical region gene 9, a long noncoding RNA, in gastric cancer

Ni C, Yang P, Guo J, Ye M

OncoTargets and Therapy 2018, 11:2259-2267

Published Date: 19 April 2018

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine

De Lorenzo C, Paciello R, Riccio G, Rea D, Barbieri A, Coppola C, Maurea N

OncoTargets and Therapy 2018, 11:2241-2250

Published Date: 19 April 2018

microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma

Gao X, Zhu Y, Li JH, Wang X, Zhang X, Yi C, Yang X

OncoTargets and Therapy 2018, 11:2227-2239

Published Date: 19 April 2018

EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients

Lu HY, Qin J, Han N, Lei L, Xie F, Li C

OncoTargets and Therapy 2018, 11:2217-2226

Published Date: 20 April 2018

miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5

Wei X, Yu L, Kong X

OncoTargets and Therapy 2018, 11:2205-2216

Published Date: 18 April 2018

miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression

Du L, Chen T, Zhao K, Yang D

OncoTargets and Therapy 2018, 11:2195-2202

Published Date: 17 April 2018

The role of Hippo signal pathway in breast cancer metastasis

Wei C, Wang Y, Li X

OncoTargets and Therapy 2018, 11:2185-2193

Published Date: 17 April 2018

Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females

Huang Y, Jian W, Zhao J, Wang G

OncoTargets and Therapy 2018, 11:2177-2184

Published Date: 17 April 2018

Preoperative apolipoprotein B/apolipoprotein A1 ratio: a novel prognostic factor for gastric cancer

Ma MZ, Yuan SQ, Chen Y, Zhou ZW

OncoTargets and Therapy 2018, 11:2169-2176

Published Date: 13 April 2018

Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis

Zhou Y, Cheng S, Chen S, Zhao Y

OncoTargets and Therapy 2018, 11:2157-2167

Published Date: 13 April 2018

Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer

Wang HY, Yu X, Fan Y, Jiang Y

OncoTargets and Therapy 2018, 11:2149-2155

Published Date: 13 April 2018

Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients

Liu C, Wang W, Meng XY, Sun B, Cong Y, Liu JN, Wang Q, Liu GX, Wu SK

OncoTargets and Therapy 2018, 11:2131-2139

Published Date: 12 April 2018

Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma

Huang CK, Huang ZC, Zhao XK, Wang YH, Zhao HQ, Zhong ZH, Wang L

OncoTargets and Therapy 2018, 11:2111-2120

Published Date: 12 April 2018

Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells

An S, Huang L, Miao P, Shi L, Shen M, Zhao X, Liu J, Huang G

OncoTargets and Therapy 2018, 11:2097-2109

Published Date: 13 April 2018

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

Abdel-Razeq H, Saadeh SS, Abu-Nasser M, Abdulelah H, Marie L, Salam M, Al-Haj Ali B, Ibrahim M, Rimawi D

OncoTargets and Therapy 2018, 11:2091-2096

Published Date: 11 April 2018

Investigation of LEP and LEPR polymorphisms with the risk of hepatocellular carcinoma: a case–control study in Eastern Chinese Han population

Zhang S, Jiang J, Chen Z, Wang Y, Tang W, Liu C, Liu L, Chen Y

OncoTargets and Therapy 2018, 11:2083-2089

Published Date: 11 April 2018

Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis

Huang CK, Huang ZC, Bai PM, Luo GC, Zhao XK, Wang XJ

OncoTargets and Therapy 2018, 11:2075-2082

Published Date: 11 April 2018

Role of the NFκB-signaling pathway in cancer

Xia LZ, Tan SM, Zhou YJ, Lin JG, Wang HR, Oyang LD, Tian YT, Liu L, Su M, Wang H, Cao D, Liao QJ

OncoTargets and Therapy 2018, 11:2063-2073

Published Date: 11 April 2018

Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancer

Tan J, Liu Y, Maimaiti Y, Wang C, Yan Y, Zhou J, Ruan S, Huang T

OncoTargets and Therapy 2018, 11:2051-2061

Published Date: 11 April 2018

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion

Liu S, Ding G, Zhou Z, Feng C

OncoTargets and Therapy 2018, 11:2029-2036

Published Date: 9 April 2018

Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity

Yao C, Liu B, Qian X, Li L, Cao H, Guo Q, Zhou G

OncoTargets and Therapy 2018, 11:2017-2028

Published Date: 9 April 2018

Butein activates p53 in hepatocellular carcinoma cells via blocking MDM2-mediated ubiquitination

Zhou Y, Wang K, Zhou N, Huang T, Zhu J, Li J

OncoTargets and Therapy 2018, 11:2007-2015

Published Date: 6 April 2018

Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus

Peng C, Gu L, Wang L, Huang Q, Wang B, Guo G, Fan Y, Gao Y, Ma X, Zhang X

OncoTargets and Therapy 2018, 11:1997-2005

Published Date: 6 April 2018

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy

Chen XX, Xia F, Luo JR, Ma JL, Yang ZZ, Zhang L, Feng Y, Shao ZM, Yu XL, Guo XM

OncoTargets and Therapy 2018, 11:1973-1980

Published Date: 5 April 2018

Inhibition of NIPBL enhances the chemosensitivity of non-small-cell lung cancer cells via the DNA damage response and autophagy pathway

Zheng L, Zhou H, Guo L, Xu X, Zhang S, Xu W, Mao W

OncoTargets and Therapy 2018, 11:1941-1948

Published Date: 5 April 2018

Downregulation of miR-542-3p promotes cancer metastasis through activating TGF-β/Smad signaling in hepatocellular carcinoma

Zhang T, Liu W, Meng W, Zhao H, Yang Q, Gu SJ, Xiao CC, Jia CC, Fu BS

OncoTargets and Therapy 2018, 11:1929-1939

Published Date: 5 April 2018

Long-term survival with transarterial chemoembolization and radioembolization in a patient with cancers of unknown primary

Aktas G, Kus T, Metin T, Kervancioglu S, Elboga U

OncoTargets and Therapy 2018, 11:1885-1889

Published Date: 4 April 2018

Antiangiogenic effects of AA-PMe on HUVECs in vitro and zebrafish in vivo

Jing Y, Wang G, Xiao Q, Zhou Y, Wei Y, Gong Z

OncoTargets and Therapy 2018, 11:1871-1884

Published Date: 4 April 2018

Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis

Zhou L, Du Y, Kong L, Zhang X, Chen Q

OncoTargets and Therapy 2018, 11:1861-1869

Published Date: 4 April 2018

D-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer

Yu X, Lin H, Wang Y, Lv W, Zhang S, Qian Y, Deng X, Feng N, Yu H, Qian B

OncoTargets and Therapy 2018, 11:1833-1847

Published Date: 4 April 2018

Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis

Zhao W, Zang C, Zhang T, Li J, Liu R, Feng F, Lv Q, Zheng L, Tian J, Sun C

OncoTargets and Therapy 2018, 11:1821-1831

Published Date: 3 April 2018

Rare malignant insulinoma with multiple liver metastases derived from ectopic pancreas: 3-year follow-up and literature review

Liu Q, Duan JH, Zheng YM, Luo J, Cai XP, Tan HY

OncoTargets and Therapy 2018, 11:1813-1819

Published Date: 3 April 2018

Association between WWOX and the risk of malignant tumor, especially among Asians: evidence from a meta-analysis

Yuan H, Wu Y, Zhang J, Shi G, Liu D, He Y, Lu Z, Wu P, Jiang K, Miao Y

OncoTargets and Therapy 2018, 11:1801-1811

Published Date: 3 April 2018

Prognostic value of increased integrin-beta 1 expression in solid cancers: a meta-analysis

Sun Q, Zhou C, Ma R, Guo Q, Huang H, Hao J, Liu H, Shi R, Liu B

OncoTargets and Therapy 2018, 11:1787-1799

Published Date: 29 March 2018

Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells

Chiu CM, Huang SY, Chang SF, Liao KF, Chiu SC

OncoTargets and Therapy 2018, 11:1777-1785

Published Date: 29 March 2018

Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells

Mu Q, Jiang M, Zhang Y, Wu F, Li H, Zhang W, Wang F, Liu J, Li L, Wang D, Wang W, Li S, Song H, Tang D

OncoTargets and Therapy 2018, 11:1767-1776

Published Date: 3 April 2018

miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells

Meng X, Fu R

OncoTargets and Therapy 2018, 11:1757-1765

Published Date: 29 March 2018

Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers

Dou YL, Lv YL, Zhou XJ, He LF, Liu LH, Li PF, Sun YL, Wang MH, Gao MJ, Wang C

OncoTargets and Therapy 2018, 11:1743-1756

Published Date: 28 March 2018

MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma

Lu Z, Du M, Qian L, Zhang N, Gu J, Ding K, Wu J, Zhu H, He X, Yin L

OncoTargets and Therapy 2018, 11:1733-1741

Published Date: 27 March 2018

miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer

Bao M, Song YJ, Xia JJ, Li PL, Liu Q, Wan ZR

OncoTargets and Therapy 2018, 11:1721-1732

Published Date: 26 March 2018

KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer

Wu Y, Wang A, Zhu B, Huang J, Lu E, Xu H, Xia W, Dong G, Jiang F, Xu L

OncoTargets and Therapy 2018, 11:1707-1720

Published Date: 28 March 2018

Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma

Wang X, Zhang J, Wang Y, Tu M, Wang Y, Shi G

OncoTargets and Therapy 2018, 11:1697-1706

Published Date: 26 March 2018

Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer

Yuan W, Xie S, Wang M, Pan S, Huang X, Xiong M, Xiao R, Xiong J, Zhang Q, Shao L

OncoTargets and Therapy 2018, 11:1683-1695

Published Date: 23 March 2018

MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1

Yao YF, Li QR, Wang H

OncoTargets and Therapy 2018, 11:1671-1681

Published Date: 23 March 2018

The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women

Ding J, Guo Y, Li Q, Chen J, Hu P, Liu Q, Cao Y, Wu J

OncoTargets and Therapy 2018, 11:1665-1670

Published Date: 23 March 2018

Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy

Boogerd LS, van der Valk MJM, Boonstra MC, Prevoo HA, Hilling DE, van de Velde CJ, Sier CF, Fariña Sarasqueta A, Vahrmeijer AL

OncoTargets and Therapy 2018, 11:1655-1664

Published Date: 23 March 2018

miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect

Liu W, Kang L, Han J, Wang Y, Shen C, Yan Z, Tai Y, Zhao C

OncoTargets and Therapy 2018, 11:1643-1653

Published Date: 23 March 2018

Effects of isoliquiritigenin on ovarian cancer cells

Li N, Yang L, Deng XN, Sun YN

OncoTargets and Therapy 2018, 11:1633-1642

Published Date: 22 March 2018

Tooth loss and risk of colorectal cancer: a dose–response meta-analysis of prospective cohort studies

Ma P, Dai S, Jin C, Yao Y, Zou C

OncoTargets and Therapy 2018, 11:1617-1623

Published Date: 21 March 2018

Lung squamous cell carcinoma associated with hypoparathyroidism with sensorineural deafness and renal dysplasia syndrome: a case report

Kojima M, Nagano T, Nakata K, Hara S, Katsurada N, Yamamoto M, Tachihara M, Kamiryo H, Kobayashi K, Usui T, Nishimura Y

OncoTargets and Therapy 2018, 11:1595-1599

Published Date: 20 March 2018

High expression of COL10A1 is associated with poor prognosis in colorectal cancer

Huang H, Li T, Ye G, Zhao L, Zhang Z, Mo D, Wang Y, Zhang C, Deng H, Li G, Liu H

OncoTargets and Therapy 2018, 11:1571-1581

Published Date: 20 March 2018

Novel long noncoding RNA GACAT3 promotes colorectal cancer cell proliferation, invasion, and migration through miR-149

Zhou W, Wang L, Miao Y, Xing R

OncoTargets and Therapy 2018, 11:1543-1552

Published Date: 19 March 2018

Functional miRNAs in breast cancer drug resistance

Hu WZ, Tan CL, He YJ, Zhang GQ, Xu Y, Tang JH

OncoTargets and Therapy 2018, 11:1529-1541

Published Date: 19 March 2018

Primary mucinous carcinoma of thyroid gland with prominent signet-ring-cell differentiation: a case report and review of the literature

Wang J, Guli QR, Ming XC, Zhou HT, Cui YJ, Jiang YF, Zhang D, Liu Y

OncoTargets and Therapy 2018, 11:1521-1528

Published Date: 16 March 2018

STK39 blockage by RNA interference inhibits the proliferation and induces the apoptosis of renal cell carcinoma

Zhao Q, Zhu YJ, Liu L, Wang H, Jiang S, Hu X, Guo J

OncoTargets and Therapy 2018, 11:1511-1519

Published Date: 16 March 2018

miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma

Wang R, Ma Q, Ji L, Yao Y, Ma M, Wen Q

OncoTargets and Therapy 2018, 11:1501-1509

Published Date: 16 March 2018

Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: a meta-analysis

Yu G, Zhang W, Zhu L, Xia L

OncoTargets and Therapy 2018, 11:1491-1499

Published Date: 16 March 2018

Midazolam activates caspase, MAPKs and endoplasmic reticulum stress pathways, and inhibits cell cycle and Akt pathway, to induce apoptosis in TM3 mouse Leydig progenitor cells

Kang FC, Wang SC, Chang MM, Pan BS, Wong KL, Cheng KS, So EC, Huang BM

OncoTargets and Therapy 2018, 11:1475-1490

Published Date: 15 March 2018

Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis

Yang X, Zhu S, Li L, Zhang L, Xian S, Wang Y, Cheng Y

OncoTargets and Therapy 2018, 11:1457-1474

Published Date: 15 March 2018

Measurement of serum PODXL concentration for detection of pancreatic cancer

Taniuchi K, Tsuboi M, Sakaguchi M, Saibara T

OncoTargets and Therapy 2018, 11:1433-1445

Published Date: 15 March 2018

Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy

Qian Y, Tao J, Li X, Chen H, Lu Q, Yang J, Pan H, Wang C, Zhou W, Liu X

OncoTargets and Therapy 2018, 11:1423-1432

Published Date: 15 March 2018

Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients

Donizy P, Pagacz K, Marczuk J, Fendler W, Maciejczyk A, Halon A, Matkowski R

OncoTargets and Therapy 2018, 11:1413-1422

Published Date: 14 March 2018

Long non-coding RNA FENDRR inhibits cell proliferation and is associated with good prognosis in breast cancer

Li Y, Zhang W, Liu P, Xu Y, Tang L, Chen W, Guan X

OncoTargets and Therapy 2018, 11:1403-1412

Published Date: 14 March 2018

Fast hemostasis: a win-win strategy for ultrasound and microwave ablation

Guo J, Tian G, Zhao Q, Jiang T

OncoTargets and Therapy 2018, 11:1395-1402

Published Date: 13 March 2018

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer

Cymbaluk-Płoska A, Chudecka-Głaz A, Jagodzińska A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Menkiszak J

OncoTargets and Therapy 2018, 11:1363-1372

Published Date: 13 March 2018

Clinicopathological features and prognosis in elderly gastric cancer patients: a retrospective cohort study

Xu G, Feng F, Liu S, Wang F, Zheng G, Wang Q, Cai L, Guo M, Lian X, Zhang H

OncoTargets and Therapy 2018, 11:1353-1362

Published Date: 12 March 2018

SPP1 promotes ovarian cancer progression via Integrin β1/FAK/Akt signaling pathway

Zeng B, Zhou M, Wu H, Xiong Z

OncoTargets and Therapy 2018, 11:1333-1343

Published Date: 12 March 2018

CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis

Zhang ZX, Zhang WN, Sun YY, Li YH, Xu ZM, Fu WN

OncoTargets and Therapy 2018, 11:1323-1331

Published Date: 8 March 2018

Clinicopathological characteristics and prognosis of adult ovarian granulosa cell tumor: a single-institution experience in China

Wang D, Xiang Y, Wu M, Shen K, Yang J, Huang H, Ren T

OncoTargets and Therapy 2018, 11:1315-1322

Published Date: 7 March 2018

Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma

Yang WJ, Qu Y, Tan BX, Jia YB, Wang NN, Hu P, Wang JB

OncoTargets and Therapy 2018, 11:1305-1314

Published Date: 7 March 2018

The clinicopathological and prognostic value of HSP27 in hepatocellular carcinoma: a systematic review and meta-analysis

Liang CJ, Xu YC, Ge H, Li GM, Wu JX

OncoTargets and Therapy 2018, 11:1293-1303

Published Date: 7 March 2018

Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer

Bai WK, Zhang W, Hu B

OncoTargets and Therapy 2018, 11:1267-1274

Published Date: 6 March 2018

Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection

Li D, Zhou Y, Liu Y, Lin Y, Yu M, Lu X, Huang B, Sun Z, Jian Z, Hou B

OncoTargets and Therapy 2018, 11:1259-1265

Published Date: 6 March 2018

A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study

Yalcin Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyilkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E

OncoTargets and Therapy 2018, 11:1223-1228

Published Date: 5 March 2018

Leukemia-related protein 16 (LRP16) promotes tumor growth and metastasis in pancreatic cancer

Mo Z, Hu MG, Yu F, Shao LJ, Fan KX, Jiao SC

OncoTargets and Therapy 2018, 11:1215-1222

Published Date: 5 March 2018

Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma

Liang CJ, Xu Y, Ge H, Li G, Wu J

OncoTargets and Therapy 2018, 11:1203-1214

Published Date: 5 March 2018

Impact of diabetes mellitus on the risk and survival of nasopharyngeal carcinoma: a meta-analysis

Guo G, Fu M, Wei S, Chen R

OncoTargets and Therapy 2018, 11:1193-1201

Published Date: 2 March 2018

Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma

Wang R, Deng D, Shao N, Xu Y, Xue L, Peng Y, Liu Y, Zhi F

OncoTargets and Therapy 2018, 11:1183-1192

Published Date: 2 March 2018

Hepatitis C virus core impacts expression of miR122 and miR204 involved in carcinogenic progression via regulation of TGFBRAP1 and HOTTIP expression

Wang X, Peng J, Wang J, Li M, Wu D, Wu S, Liao J, Dou J

OncoTargets and Therapy 2018, 11:1173-1182

Published Date: 2 March 2018

Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study

Zheng XY, Wang Y, Dong LL, Zhao S, Wang LP, Chen H, Xu Y, Wang GN

OncoTargets and Therapy 2018, 11:1141-1148

Published Date: 1 March 2018

rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysis

Liu Y, He A, Liu B, Zhong Y, Liao X, Yang J, Chen J, Wu J, Mei H

OncoTargets and Therapy 2018, 11:1121-1139

Published Date: 1 March 2018

Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion

Aguado C, Gil MDLL, Yeste Z, Giménez-Capitán A, Teixidó C, Karachaliou N, Viteri S, Rosell R, Molina-Vila MA

OncoTargets and Therapy 2018, 11:1117-1120

Published Date: 1 March 2018

The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis

Fan JS, Xia ZF, Zhang XL, Chen YQ, Qian RL, Liu SH, You DM, Zhang J, Luo P

OncoTargets and Therapy 2018, 11:1105-1115

Published Date: 1 March 2018

TSPAN12 is overexpressed in NSCLC via p53 inhibition and promotes NSCLC cell growth in vitro and in vivo

Hu Z, Hou D, Wang X, You Z, Cao X

OncoTargets and Therapy 2018, 11:1095-1103

Published Date: 1 March 2018

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer

Jiang DG, Xiao CT, Xian TZ, Wang LT, Mao YH, Zhang JF, Pang J

OncoTargets and Therapy 2018, 11:1077-1086

Published Date: 28 February 2018

Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis

Wang B, Zhang XB, Wang W, Zhu ZZ, Tang F, Wang D, Liu X, Zhuang H, Yan XL

OncoTargets and Therapy 2018, 11:1067-1075

Published Date: 27 February 2018

Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis

Tang L, Li J, Bao M, Xiang J, Chen Y, Wang Y

OncoTargets and Therapy 2018, 11:1055-1066

Published Date: 1 March 2018

CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis

Zhang Y, Xu L, Peng M

OncoTargets and Therapy 2018, 11:1045-1054

Published Date: 27 February 2018

Clinicopathologic characteristics and prognosis of proximal and distal gastric cancer

Yu X, Hu F, Li C, Yao Q, Zhang H, Xue Y

OncoTargets and Therapy 2018, 11:1037-1044

Published Date: 27 February 2018

Reversine, a substituted purine, exerts an inhibitive effect on human renal carcinoma cells via induction of cell apoptosis and polyploidy

Cheng L, Wang H, Guo KC, Wang ZC, Zhang ZY, Shen C, Chen L, Lin J

OncoTargets and Therapy 2018, 11:1025-1035

Published Date: 26 February 2018

Prognostic significance of Epstein–Barr virus DNA in NK/T-cell lymphoma: a meta-analysis

Fei Q, Tian X, Wu J, Zhu H, Wang Y, Peng F, Zhang W, Yin L, He X

OncoTargets and Therapy 2018, 11:997-1004

Published Date: 26 February 2018

Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway

Yang C, Hou A, Yu C, Dai L, Wang W, Zhang K, Shao H, Ma J, Xu W

OncoTargets and Therapy 2018, 11:983-996

Published Date: 26 February 2018

Prognostic significance of mucinous component in gastric adenocarcinoma after radical D2 gastrectomy

Cai L, Li Y, Yang X, Lian X, Guo M, Xiao S, Wang W, Zhang H

OncoTargets and Therapy 2018, 11:967-973

Published Date: 23 February 2018

Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells

Wang X, Liu Y, Wu R, Guo F, Zhang L, Cui M, Wu X, Zhang Y, Liu W

OncoTargets and Therapy 2018, 11:943-953

Published Date: 22 February 2018

Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines

Sipos E, Dobos N, Rozsa D, Fodor K, Olah G, Szabo Z, Szekvolgyi L, Schally AV, Halmos G

OncoTargets and Therapy 2018, 11:933-941

Published Date: 22 February 2018

The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing

Yang F, Xu S, Liu RW, Shi T, Li XF, Li XB, Chen G, Liu HY, Zhou QH, Chen J

OncoTargets and Therapy 2018, 11:919-932

Published Date: 21 February 2018

Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma

Sheng XR, Xing SG, Wang RD, Chen K, Jia WD

OncoTargets and Therapy 2018, 11:909-917

Published Date: 21 February 2018

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker

Shen Z, Yu X, Zheng Y, Lai X, Li J, Hong Y, Zhang H, Chen C, Su Z, Guo R

OncoTargets and Therapy 2018, 11:891-901

Published Date: 20 February 2018

Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review

Bi MH, Yang JR, Wang YP, Zhang HR, Gao ZY, Zhou HR, Shi MH

OncoTargets and Therapy 2018, 11:883-890

Published Date: 19 February 2018

Klotho ameliorates sepsis-induced acute kidney injury but is irrelevant to autophagy

Chen X, Tong H, Chen Y, Chen C, Ye J, Mo Q, Zhao G, Hong G, Zheng C, Lu Z

OncoTargets and Therapy 2018, 11:867-881

Published Date: 19 February 2018

Effects of four single nucleotide polymorphisms of EZH2 on cancer risk: a systematic review and meta-analysis

Ling Z, You Z, Hu L, Zhang L, Wang Y, Zhang M, Zhang G, Chen S, Xu B, Chen M

OncoTargets and Therapy 2018, 11:851-865

Published Date: 16 February 2018

Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells

Yang Z, Gao X, Wang J, Xu L, Zheng Y, Xu Y

OncoTargets and Therapy 2018, 11:843-849

Published Date: 16 February 2018

Developments in the management of advanced soft-tissue sarcoma – olaratumab in context

Moroncini G, Maccaroni E, Fiordoliva I, Pellei C, Gabrielli A, Berardi R

OncoTargets and Therapy 2018, 11:833-842

Published Date: 16 February 2018

MiR-1180-5p regulates apoptosis of Wilms’ tumor by targeting p73

Jiang X, Li H

OncoTargets and Therapy 2018, 11:823-831

Published Date: 16 February 2018

Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting

Wu Z, Xu S, Zhou L, Yin W, Lin Y, Du Y, Wang Y, Jiang Y, Yin K, Zhang J, Lu J

OncoTargets and Therapy 2018, 11:801-808

Published Date: 15 February 2018

The association between HOTAIR polymorphisms and cancer susceptibility: an updated systemic review and meta-analysis

Min L, Mu X, Tong A, Qian Y, Ling C, Yi T, Zhao X

OncoTargets and Therapy 2018, 11:791-800

Published Date: 14 February 2018

ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis

Li L, Sun F, Chen X, Zhang M

OncoTargets and Therapy 2018, 11:781-789

Published Date: 14 February 2018

Raptor mediates the antiproliferation of cardamonin by mTORC1 inhibition in SKOV3 cells

Shi D, Zhu Y, Niu P, Zhou J, Chen H

OncoTargets and Therapy 2018, 11:757-767

Published Date: 9 February 2018

Molecular features of giant-cell carcinoma of the lung: a case report and literature review

Li X, Zhang ZH, Liu JH, Wang D, Wei S, Chen J

OncoTargets and Therapy 2018, 11:751-756

Published Date: 9 February 2018

Expression of Nemo-like kinase in cervical squamous cell carcinoma: a clinicopathological study

Yang W, Gu L, Yang C, Liu T

OncoTargets and Therapy 2018, 11:743-749

Published Date: 8 February 2018

Prognostic significance of epidermal growth factor receptor expression in glioma patients

Li JH, Liang RF, Song C, Xiang YF, Liu YH

OncoTargets and Therapy 2018, 11:731-742

Published Date: 7 February 2018

Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis

Dai P, Li J, Ma XP, Huang J, Meng JJ, Gong P

OncoTargets and Therapy 2018, 11:721-730

Published Date: 5 February 2018

Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies

Han X, Han Y, Zheng Y, Sun Q, Ma T, Dai L, Zhang J, Xu L

OncoTargets and Therapy 2018, 11:711-720

Published Date: 5 February 2018

PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells [Corrigendum]

Guo L, Huang S, Wang X

OncoTargets and Therapy 2018, 11:687-688

Published Date: 2 February 2018

Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer

Xie L, Li X, Wang Q, Zhou J, Shen J, Luo L, Lu Y, Wang L

OncoTargets and Therapy 2018, 11:677-685

Published Date: 1 February 2018

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

Tang LN, Zhang CL, He HR, Pan ZY, Fan D, He YL, You HS, Li YJ

OncoTargets and Therapy 2018, 11:665-675

Published Date: 1 February 2018

Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance

Li J, Ye D, Wang L, Peng Y, Li Q, Deng H, Zhou C

OncoTargets and Therapy 2018, 11:651-663

Published Date: 1 February 2018

LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1

Shang M, Wang X, Zhang Y, Gao Z, Wang T, Liu R

OncoTargets and Therapy 2018, 11:639-649

Published Date: 31 January 2018

The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer

Hu YY, Qi EP, Liu FY, Lu YH, Tan SL, Sun Y, Han ZY, Liang P, Yu XL

OncoTargets and Therapy 2018, 11:619-627

Published Date: 31 January 2018

Identification of genomic expression differences between right-sided and left-sided colon cancer based on bioinformatics analysis

Peng Q, Lin K, Chang T, Zou L, Xing P, Shen Y, Zhu Y

OncoTargets and Therapy 2018, 11:609-618

Published Date: 31 January 2018

ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3

Wang Y, Shao F, Chen L

OncoTargets and Therapy 2018, 11:599-608

Published Date: 31 January 2018

Clinical manifestations of pulmonary mucosa-associated lymphoid tissue lymphoma: single-center experience with 18 patients

Zhao S, Zhang L, Gu Z, Zhu C, Fang S, Yang N, Wang F, Guan L, Luo L, Gao C

OncoTargets and Therapy 2018, 11:555-561

Published Date: 24 January 2018

Quantification of heart, pericardium, and left ventricular myocardium movements during the cardiac cycle for thoracic tumor radiotherapy

Tong Y, Yin Y, Lu J, Liu T, Chen J, Cheng P, Gong G

OncoTargets and Therapy 2018, 11:547-554

Published Date: 24 January 2018

Nomogram for predicting survival in patients with pancreatic cancer

Song W, Miao DL, Chen L

OncoTargets and Therapy 2018, 11:539-545

Published Date: 24 January 2018

The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review

Zhang S, Xu XS, Yang JX, Guo JH, Chao TF, Tong YX

OncoTargets and Therapy 2018, 11:509-519

Published Date: 23 January 2018

Prognostic role of neutrophil–lymphocyte ratio in multiple myeloma: a dose–response meta-analysis

Mu S, Ai L, Fan F, Sun C, Hu Y

OncoTargets and Therapy 2018, 11:499-507

Published Date: 23 January 2018

ROS-dependent Bax/Bcl2 and caspase 3 pathway-mediated apoptosis induced by zineb in human keratinocyte cells

Ali D, Tripathi A, Al Ali H, Shahi Y, Mishra KK, Alarifi S, Alkahtane AA, Manohardas S

OncoTargets and Therapy 2018, 11:489-497

Published Date: 23 January 2018

Synovial sarcoma of the maxillary sinus: an extremely rare case with excellent response to chemotherapy

Saito S, Ozawa H, Ikari Y, Nakahara N, Ito F, Sekimizu M, Fukada J, Kameyama K, Ogawa K

OncoTargets and Therapy 2018, 11:483-488

Published Date: 23 January 2018

Apatinib-treated advanced medullary thyroid carcinoma: a case report

Chen K, Gao Y, Shi F, Cao G, Bao J

OncoTargets and Therapy 2018, 11:459-463

Published Date: 19 January 2018

Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran

Boostani F, Dolatkhah R, Fakhrjou A, Farassati F, Sanaat Z

OncoTargets and Therapy 2018, 11:449-457

Published Date: 19 January 2018

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma

Chen JW, Huang CQ, Chen K, Li SM, Zhang X, Cheng J, Cai MY, Xiao Y

OncoTargets and Therapy 2018, 11:441-448

Published Date: 19 January 2018

Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

Sevinç A, Özkan M, Özet A, Dane F, Öksüzoğlu B, Işıkdoğan A, Özdemir F, Uncu D, Gümüş M, Evrensel T, Yaren A, Kara O, Tekin SB

OncoTargets and Therapy 2018, 11:419-426

Published Date: 18 January 2018

Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study

Chang H, Yu X, Xiao W, Wang QX, Zhou WH, Zeng ZF, Ding PR, Li L, Gao YH

OncoTargets and Therapy 2018, 11:409-418

Published Date: 17 January 2018

Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway

Daya M, Loilome W, Techasen A, Thanee M, Sa-Ngiamwibool P, Titapun A, Yongvanit P, Namwat N

OncoTargets and Therapy 2018, 11:395-408

Published Date: 18 January 2018

Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients

Wan T, Shao J, Hu B, Liu G, Luo P, Zhou Y

OncoTargets and Therapy 2018, 11:383-393

Published Date: 17 January 2018

Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer

Liu M, Hu G, Wang Y, Guo J, Liu L, Han X, Wang Z

OncoTargets and Therapy 2018, 11:375-381

Published Date: 17 January 2018

Combination of betulinic acid with diazen-1-ium-1,2-diolate nitric oxide moiety donating a novel anticancer candidate

Zhang L, Hou S, Li B, Pan J, Jiang L, Zhou G, Gu H, Zhao C, Lu H, Ma F

OncoTargets and Therapy 2018, 11:361-373

Published Date: 15 January 2018

Prognostic role of HSPs in human gastrointestinal cancer: a systematic review and meta-analysis

Ge H, Yan Y, Guo L, Tian F, Wu D

OncoTargets and Therapy 2018, 11:351-359

Published Date: 15 January 2018

Safety and efficacy of transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the treatment of secondary liver malignancies

Schicho A, Pereira PL, Michalik K, Beyer LP, Stroszczynski C, Wiggermann P

OncoTargets and Therapy 2018, 11:345-350

Published Date: 12 January 2018

The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing

Rao C, Nie L, Miao X, Xu Y, Li B, Zhang T

OncoTargets and Therapy 2018, 11:337-344

Published Date: 12 January 2018

High-frequency deregulated expression of Wnt signaling pathway members in breast carcinomas

Khan Z, Arafah M, Shaik JP, Mahale A, Alanazi MS

OncoTargets and Therapy 2018, 11:323-335

Published Date: 11 January 2018

A novel tumor suppressor gene NCOA5 is correlated with progression in papillary thyroid carcinoma

Zheng Z, Wang Q, Zhang W, Zhang X, Huang D

OncoTargets and Therapy 2018, 11:307-311

Published Date: 11 January 2018

Comparative study of clinical efficacy using three-dimensional and two-dimensional laparoscopies in the treatment of distal gastric cancer

Liu JG, Zhou HT, Qin HQ, Ru HM, Huang JH, Liang SY, Mo XW, Tang WZ

OncoTargets and Therapy 2018, 11:301-306

Published Date: 11 January 2018

Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer

Zhang P, Zhou H, Lu K, Lu Y, Wang Y, Feng T

OncoTargets and Therapy 2018, 11:291-299

Published Date: 9 January 2018

A support vector machine and a random forest classifier indicates a 15-miRNA set related to osteosarcoma recurrence

He Y, Ma J, Wang A, Wang W, Luo S, Liu Y, Ye X

OncoTargets and Therapy 2018, 11:253-269

Published Date: 5 January 2018

miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells

Tsai TF, Lin JF, Chou KY, Lin YC, Chen HE, Hwang TIS

OncoTargets and Therapy 2018, 11:239-252

Published Date: 4 January 2018

Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance

Vert A, Castro J, Ribó M, Vilanova M, Benito A

OncoTargets and Therapy 2018, 11:221-237

Published Date: 4 January 2018

RACK1 induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression

Liu B, Wang C, Chen P, Cheng B, Cheng Y

OncoTargets and Therapy 2018, 11:211-220

Published Date: 4 January 2018

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth

Wang Y, Zang J, Zhang D, Sun Z, Qiu B, Wang X

OncoTargets and Therapy 2018, 11:201-209

Published Date: 8 January 2018

Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/β-catenin signaling

Hu P, Cheng B, He Y, Wei Z, Wu D, Meng Z

OncoTargets and Therapy 2018, 11:193-200

Published Date: 4 January 2018

The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells

Bimonte S, Barbieri A, Cascella M, Rea D, Palma G, Del Vecchio V, Forte CA, Del Prato F, Arra C, Cuomo A

OncoTargets and Therapy 2018, 11:185-191

Published Date: 3 January 2018

Cancer stem cells, the ultimate targets in cancer therapy

Shabbir A, Esfandyari T, Farassati F

OncoTargets and Therapy 2018, 11:183-184

Published Date: 3 January 2018

A patient with classic biphasic pulmonary blastoma harboring CD74–ROS1 fusion responds to crizotinib

Meng Z, Chen P, Zang F, Liu Y, Xu X, Su Y, Chen J, Lin L, Zhang L, Zhang T

OncoTargets and Therapy 2018, 11:157-161

Published Date: 28 December 2017

Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy

Castelli G, Pelosi E, Testa U

OncoTargets and Therapy 2018, 11:131-155

Published Date: 28 December 2017

Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC

Tang XM, Chen H, Li Q, Song YL, Zhang SP, Xu XS, Xu YW, Chen SL

OncoTargets and Therapy 2018, 11:123-129

Published Date: 28 December 2017

The putative tumor suppressor, miR-199a, regulated by Snail, modulates clear cell renal cell carcinoma aggressiveness by repressing ROCK1

Zhang X, Li P, Ding Z, Wang H, Wang J, Han L, Ding S

OncoTargets and Therapy 2018, 11:103-112

Published Date: 27 December 2017

The RNASEL −1385G/A polymorphism is associated with risk of prostate cancer in Africans

Liu X, Zheng D, Lu G, Yang B

OncoTargets and Therapy 2018, 11:97-102

Published Date: 22 December 2017

Prognosis of patients with primary malignant main stem bronchial tumors: 7,418 cases based on the SEER database

Ma K, Sun F, Yang X, Wang S, Wang L, Jin Y, Shi Y, Jiang W, Zhan C, Wang Q

OncoTargets and Therapy 2018, 11:83-95

Published Date: 22 December 2017

Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer

Wang Y, Jin Y, Bhandari A, Yao Z, Yang F, Pan Y, Zheng Z, Lv S, Wang O

OncoTargets and Therapy 2018, 11:37-46

Published Date: 21 December 2017

Four-miRNA signature as a prognostic tool for lung adenocarcinoma

Lin Y, Lv Y, Liang R, Yuan C, Zhang J, He D, Zheng X, Zhang J

OncoTargets and Therapy 2018, 11:29-36

Published Date: 21 December 2017

Identification of epigenetically altered genes and potential gene targets in melanoma using bioinformatic methods

Duan HH, Jiang K, Wei DK, Zhang LJ, Cheng DL, Lv M, Xu YB, He AM

OncoTargets and Therapy 2018, 11:9-15

Published Date: 20 December 2017